SIOX - Sio Gene Therapies - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

-18.39M

Cash

46.13M

Avg Qtr Burn

-9.127M

Short % of Float

0.13%

Insider Ownership

25.30%

Institutional Own.

3.98%

Qtr Updated

12/31/22

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
AXO-Lenti-PD (OXB-102) Details Parkinson's disease	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AXO-AAV-GM1 (GLB1) Details GM1 gangliosidosis, Lysosomal storage disorder	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AXO-AAV-GM2 Details Tay-Sachs/Sandhoff disease, GM2 gangliosidosis, Lysosomal storage disorder	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.